MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 31 filers reported holding MILESTONE PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $148,730 | +6.9% | 52,186 | +47.8% | 0.00% | – |
| Q1 2023 | $139,110 | -81.9% | 35,307 | -81.8% | 0.00% | -100.0% |
| Q4 2022 | $769,598 | +764.7% | 194,343 | +1097.1% | 0.00% | – |
| Q2 2021 | $89,000 | -71.9% | 16,235 | -70.4% | 0.00% | -100.0% |
| Q1 2021 | $317,000 | -17.7% | 54,813 | -4.5% | 0.00% | 0.0% |
| Q4 2020 | $385,000 | +163.7% | 57,411 | +188.5% | 0.00% | 0.0% |
| Q3 2020 | $146,000 | – | 19,902 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,530,585 | $16,955,000 | 0.73% |
| Ikarian Capital, LLC | 1,836,545 | $12,305,000 | 0.54% |
| Boxer Capital, LLC | 2,477,194 | $16,597,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,911,000 | 0.48% |
| RA Capital Management | 2,327,714 | $15,596,000 | 0.22% |
| Orbimed Advisors | 2,493,109 | $16,704,000 | 0.15% |
| PURA VIDA INVESTMENTS, LLC | 450,000 | $3,015,000 | 0.11% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,704,000 | 0.08% |
| Anson Funds Management LP | 50,113 | $336,000 | 0.07% |
| Tekla Capital Management LLC | 253,610 | $1,699,000 | 0.06% |